Comparison of the Effects of Myristoylated and Transactivating Peptide (TAT) Conjugated Mitochondrial Fission Peptide Inhibitor (P110) in Myocardial Ischemia/Reperfusion (I/R) Injury
Document Type
Article
Publication Date
2015
Publication Title
Proceedings of the 24th Annual American Peptide Symposium
Recommended Citation
Benjamin, Israel; Vu, Jonathan; Lipscombe, Christina; Stutzman, Devon; Schmigdall, Carly; Patel, Harsh; Chen, Qian; Hatcher, Cathy J.; Barsotti, Robert; and Young, Lindon H., "Comparison of the Effects of Myristoylated and Transactivating Peptide (TAT) Conjugated Mitochondrial Fission Peptide Inhibitor (P110) in Myocardial Ischemia/Reperfusion (I/R) Injury" (2015). PCOM Scholarly Works. 1654.
https://digitalcommons.pcom.edu/scholarly_papers/1654
COinS
Comments
This article was published in Proceedings of the 24th American Peptide Symposium .
The published version is available at http://dx.doi.org/10.17952/24APS.2015.143.Copyright © 2015 APS.